Posted AT 8:29 AM EDT on 07/03/08
Drug recall puts overseas inspections in spotlight
Amajor U.S. recall of a blood-thinning drug linked to a Chinese factory last week is prompting new questions over the ability of government and industry to ensure the safety of drugs made with ingredients from China.
The full text of this article has 782 words.
To continue reading this article, you will need to purchase this article.
Already have a member account? Login now
Pay-Per-View Offers To read the complete article, select one of the following options
Purchasing from globeandmail.com is quick and secure.
Choosing silence 
- 'Why not just talk about it?'
- Abortion has been unrestricted in Canada for two decades, but few women who make the choice ever talk about it
72
-
In Pictures:
Speaking out 
Breakdown
- Our mental health crisis
- Globe series tackles stigma, tells stories of Canadians
Child's View
- Focus on malaria
- Scenes from life in Liberia
Earlier discussion
slideshow
- Medical marijuna
- Alison Myrden's painful battle with MS
Features
- Confronting cancer
- Globe Series concludes with look at people who blaze trails
- Battling cancer
- Breast cancer death rates declining
-
Special report:
A day in the life
In pictures
- Best position in bed
- How you sleep can make you feel better or worse
